Literature DB >> 6397278

The impact of malaria chemoprophylaxis on the immune status of Africans.

B M Greenwood.   

Abstract

The small number of studies undertaken so far indicates that malaria control with chemoprophylaxis depresses serum gamma-globulin levels and interferes with the development of the malaria antibodies detected by standard serological tests. Whether these serological changes are associated with defective development of clinical immunity has yet to be clearly established.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6397278      PMCID： PMC2536205     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  13 in total

1.  IMMUNOLOGICAL ASPECTS OF A POPULATION UNDER PROPHYLAXIS AGAINST MALARIA.

Authors:  A VOLLER; H WILSON
Journal:  Br Med J       Date:  1964-08-29

2.  Studies on the significance of high serum gamma-globulin concentrations in Gambian Africans. III. Gamma-globulin concentrations of Gambian women protected from malaria for two years.

Authors:  H M GILLES; I A McGREGOR
Journal:  Ann Trop Med Parasitol       Date:  1961-12

3.  Studies on the significance of high serum gamma-globulin concentrations in Gambian Africans. I.-Gamma-globulin concentrations of Gambian children in the first two years of life.

Authors:  H M GILLES; I A McGREGOR
Journal:  Ann Trop Med Parasitol       Date:  1959-12

4.  Malaria in Gold Coast students on their return from the United Kingdom.

Authors:  M J COLBOURNE
Journal:  Trans R Soc Trop Med Hyg       Date:  1955-09       Impact factor: 2.184

5.  The Malumfashi project--an epidemiological, clinical and laboratory study.

Authors:  H M Gilles; B M Greenwood; A M Greenwood; A K Bradley; I Blakebrough; R N Pugh; B Musa; U Shehu; M Tayo; J Jewsbury
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

6.  Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 2. The impact of chloroquine used as a chemosuppressant on the immune status of the population.

Authors:  E Onori; B Grab; P Ambroise-Thomas; J Thelu
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

7.  The effect of malarial chemoprophylaxis on immunoglobulin levels of pregnant Nigerian women and the newborn.

Authors:  P A Ibeziako; A I Williams
Journal:  Br J Obstet Gynaecol       Date:  1980-11

8.  Suppression of malaria with pyrimethamine in Nigerian schoolchildren.

Authors:  H M ARCHIBALD; L J BRUCE-CHWATT
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

9.  Observations on the early course of untreated falciparum malaria in semi-immune African children following a short period of protection.

Authors:  G Pringle; S Avery-Jones
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

10.  Malaria in the Pare area of Tanzania. 3. The course of malaria transmission since the suspension of an experimental programme of residual insecticide spraying.

Authors:  G Pringle
Journal:  Trans R Soc Trop Med Hyg       Date:  1967       Impact factor: 2.184
View more
  3 in total

Review 1.  Malaria control in Malawi: current status and directions for the future.

Authors:  Don P Mathanga; Edward D Walker; Mark L Wilson; Doreen Ali; Terrie E Taylor; Miriam K Laufer
Journal:  Acta Trop       Date:  2011-07-08       Impact factor: 3.112

2.  Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community.

Authors:  OraLee Branch; W Martin Casapia; Dionicia V Gamboa; Jean N Hernandez; Freddy F Alava; Norma Roncal; Eugenia Alvarez; Enrique J Perez; Eduardo Gotuzzo
Journal:  Malar J       Date:  2005-06-23       Impact factor: 2.979

3.  Plasma and Cerebrospinal Fluid Beta-Endorphin Levels Show a Strong Association in Children with Cerebral Malaria.

Authors:  Oluwagbemiga O Adeodu; Oluwatosin E Olorunmoteni; Saheed B A Oseni; Efere M Obuotor
Journal:  J Pediatr Neurosci       Date:  2018 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.